Elias Björnson
Elias Björnson
University of Gothenburg, Sahlgrenska Academy, the Wallenberg Laboratory for Cardiovascular and
Verified email at
Cited by
Cited by
An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans
A Mardinoglu, H Wu, E Bjornson, C Zhang, A Hakkarainen, SM Räsänen, ...
Cell metabolism 27 (3), 559-571. e5, 2018
Integrated network analysis reveals an association between plasma mannose levels and insulin resistance
S Lee, C Zhang, M Kilicarslan, BD Piening, E Bjornson, BM Hallström, ...
Cell metabolism 24 (1), 172-184, 2016
Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD
A Mardinoglu, E Bjornson, C Zhang, M Klevstig, S Söderlund, M Ståhlman, ...
Molecular systems biology 13 (3), 916, 2017
Stratification of hepatocellular carcinoma patients based on acetate utilization
E Björnson, B Mukhopadhyay, A Asplund, N Pristovsek, R Cinar, ...
Cell reports 13 (9), 2014-2026, 2015
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity
MR Taskinen, S Söderlund, LH Bogl, A Hakkarainen, N Matikainen, ...
Journal of internal medicine 282 (2), 187-201, 2017
Kinetics of plasma triglycerides in abdominal obesity
E Björnson, M Adiels, MR Taskinen, J Borén
Current opinion in lipidology 28 (1), 11-18, 2017
Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single‐centre randomized …
N Matikainen, S Söderlund, E Björnson, K Pietiläinen, A Hakkarainen, ...
Diabetes, obesity and metabolism 21 (1), 84-94, 2019
Extensive weight loss reveals distinct gene expression changes in human subcutaneous and visceral adipose tissue
A Mardinoglu, JT Heiker, D Gärtner, E Björnson, MR Schön, G Flehmig, ...
Scientific reports 5 (1), 1-11, 2015
Personalized cardiovascular disease prediction and treatment—a review of existing strategies and novel systems medicine tools
E Björnson, J Borén, A Mardinoglu
Frontiers in Physiology 7, 2, 2016
Prevalence of subclinical coronary artery atherosclerosis in the general population
G Bergström, M Persson, M Adiels, E Björnson, C Bonander, H Ahlström, ...
Circulation 144 (12), 916-929, 2021
Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics
E Björnson, CJ Packard, M Adiels, L Andersson, N Matikainen, ...
Journal of internal medicine 285 (5), 562-577, 2019
Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia
M Adiels, MR Taskinen, E Björnson, L Andersson, N Matikainen, ...
Diabetes, obesity and metabolism 21 (8), 1861-1870, 2019
Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome
A Lovric, M Granér, E Bjornson, M Arif, R Benfeitas, K Nyman, M Ståhlman, ...
Scientific reports 8 (1), 1-14, 2018
The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease
C Zhang, E Bjornson, M Arif, A Tebani, A Lovric, R Benfeitas, M Ozcan, ...
Molecular systems biology 16 (4), e9495, 2020
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans
J Borén, M Adiels, E Björnson, N Matikainen, S Söderlund, J Rämö, ...
JCI insight 5 (24), 2020
Complex I is bypassed during high intensity exercise
A Nilsson, E Björnson, M Flockhart, FJ Larsen, J Nielsen
Nature communications 10 (1), 1-11, 2019
Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men
N Matikainen, S Söderlund, E Björnson, LH Bogl, KH Pietiläinen, ...
Nutrition, Metabolism and Cardiovascular Diseases 27 (6), 534-542, 2017
Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐and hypertriglyceridemic human subjects
E Björnson, CJ Packard, M Adiels, L Andersson, N Matikainen, ...
Journal of internal medicine 288 (4), 422-438, 2020
Minor contribution of endogenous GLP-1 and GLP-2 to postprandial lipemia in obese men
N Matikainen, E Björnson, S Söderlund, C Boren, B Eliasson, ...
PloS one 11 (1), e0145890, 2016
Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects
MR Taskinen, E Björnson, L Andersson, J Kahri, K Porthan, N Matikainen, ...
Journal of Clinical Lipidology 14 (1), 77-87, 2020
The system can't perform the operation now. Try again later.
Articles 1–20